P gene variants and response to lamivudine in patients with chronic hepatitis B.

被引：0
|
作者：
Buti, M
Rodriguez-Frias, F
Eva, CD
Cotrina, M
Esteban, R
Guardia, J
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] GLAXO WELLCOME, Madrid, Spain
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1942
引用
收藏
页码：646A / 646A
页数：1
相关论文
共 50 条
  • [1] Lamivudine withdrawal hepatitis flare successfully treated with lamivudine in patients with chronic hepatitis B.
    Honkoop, P
    deMan, RA
    Niesters, HGM
    Schalm, SW
    HEPATOLOGY, 1997, 26 (04) : 1204 - 1204
  • [2] Lamivudine for the treatment of chronic hepatitis B.
    Verhelst, D
    Goffin, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08): : 592 - 592
  • [3] Response to extended lamivudine treatment of HBeAg negative chronic hepatitis B.
    Andreone, P
    Hussain, MT
    Lok, AS
    Gramenzi, A
    Cursaro, C
    Lorenzini, S
    Porzio, F
    Margotti, M
    HEPATOLOGY, 2001, 34 (04) : 321A - 321A
  • [4] Extended lamivudine retreatment for chronic hepatitis B.
    Dienstag, JL
    Schiff, ER
    Mitchell, M
    Gitlin, N
    Lissoos, T
    Condreay, L
    Garrett, L
    Rubin, M
    Brown, N
    HEPATOLOGY, 1996, 24 (04) : 245 - 245
  • [5] Efficacy of lamivudine in patients with antiHBe plus chronic active hepatitis B.
    Demelia, L
    Civolani, A
    Sorbello, O
    Murru, A
    HEPATOLOGY, 2001, 34 (04) : 634A - 634A
  • [6] Response to lamivudine therapy in chronic hepatitis B patients in Bangladesh
    Khan, M
    Alam, AKMK
    Rahman, S
    Azam, G
    Ahmad, N
    JOURNAL OF HEPATOLOGY, 2002, 36 : 240 - 240
  • [7] Resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B.
    Osiowy, C
    Heathcote, J
    Zoulim, F
    Willems, B
    Villeneuve, JP
    HEPATOLOGY, 2005, 42 (04) : 586A - 587A
  • [8] Genotypic and phenotypic resistance to lamivudine in patients with HBeAg negative chronic hepatitis B.
    Hussain, MT
    Carmela, C
    Gramenzi, A
    Fiorino, S
    Margotti, M
    Talarico, S
    Bernardi, M
    Andreone, P
    Lok, AS
    HEPATOLOGY, 2001, 34 (04) : 325A - 325A
  • [9] Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
    Gauthier, J
    Bourne, EJ
    Lutz, MW
    Crowther, LM
    Dienstag, JL
    Brown, NA
    Condreay, LD
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06): : 1757 - 1762
  • [10] Efficacy of Lamivudine in patients with cirrhosis due to hepatitis B.
    Moskovitz, DN
    Lilly, LB
    Tomlinson, G
    Heathcote, J
    HEPATOLOGY, 2001, 34 (04) : 625A - 625A
12345